ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

NAMBI SALGUNAN MD

20 COMMUNITY LN INFIRMARY ROAD

Liberty | New York | 12754

(845) 292-8770

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,060Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 1478

$876K Total Retail Price of All Prescriptions

Rank: 23 out of 1478

258 Patients Receiving at Least One Drug in Part D
19%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

14% of this provider’s 1,247 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$124 was the average price of a prescription from this provider, compared to $124 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
RISPERIDONE 583 89 1 1
BENZTROPINE MESYLATE 405 62 R 2 4
ABILIFY 401 145 3 5
DIVALPROEX SODIUM 320 71 4 17
OLANZAPINE 311 52 5 9
TOPIRAMATE 308 26 6 33
CLOZAPINE 283 22 7 10
BUSPIRONE HCL 280 55 8 23
QUETIAPINE FUMARATE 280 81 8 7
HYDROXYZINE PAMOATE 276 63 R 10 34
HYDROXYZINE HCL 219 15 R 11 37
TRAZODONE HCL 204 58 12 8
OXCARBAZEPINE 160 18 13 40
LAMOTRIGINE 158 39 14 15
FLUVOXAMINE MALEATE 151 15 15 46
CARBAMAZEPINE 146 51 16 50
THIOTHIXENE 143 16 17 65
SEROQUEL 130 25 18 27
FLUOXETINE HCL 130 0 18 12
LITHIUM CARBONATE 128 0 20 21
CHLORPROMAZINE HCL 127 49 21 44
CYMBALTA 121 0 22 13
ESCITALOPRAM OXALATE 116 17 23 18
SERTRALINE HCL 105 19 24 3
DIVALPROEX SODIUM ER 105 0 24 14
DOXEPIN HCL 97 14 26 52
TRIHEXYPHENIDYL HCL 90 0 R 27 39
GABAPENTIN 89 12 28 24
CITALOPRAM HBR 80 12 29 6
THIORIDAZINE HCL 77 12 R 30 60
PAROXETINE HCL 73 41 31 19
SEROQUEL XR 69 11 32 25
BUPROPION XL 65 0 33 16
ZOLPIDEM TARTRATE 53 13 34 2
MIRTAZAPINE 50 14 35 11
LEXAPRO 50 0 35 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 6, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.